TG THERAPEUTICS, INC. (TGTX) Gross profit 2021–2025
TG THERAPEUTICS, INC. (TGTX) annual gross profit history from SEC filings — each fiscal year as reported.
$515.6MFY2025 · since FY2021: $5.9M → $515.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $515.6M | +77.5% |
| FY2024 | $290.5M | +32.3% |
| FY2023 | $219.5M | +8611.5% |
| FY2022 | $2.5M | -57.3% |
| FY2021 | $5.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TGTX financial trends
TGTX RevenueTGTX Net incomeTGTX Net marginTGTX Gross marginTGTX Operating incomeTGTX Operating marginTGTX Operating cash flowTGTX Free cash flowTGTX Capital expendituresTGTX Return on equityTGTX Stock buybacksTGTX Dividends paidTGTX Total assetsTGTX Total liabilitiesTGTX Shareholders’ equityTGTX overview →